6 Results for "

G3BP inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "G3BP inhibitor" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-162288
CAS No.: 3036029-72-5
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

FAZ-3532 is a G3BP inhibitor (Kd = 0.54 μM) which binds to the NTF2L nsP3 binding pocket in G3BP1. FAZ-3532 disrupts the co-condensation of RNA, G3BP1, and caprin 1. FAZ-3532 inhibits G3BP-driven stress granule formation. FAZ-3532 can be studied as a powerful tool to probe the biology of stress granules and a promising interventions designed to modulate stress granule formation .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-162289
CAS No.: 3036029-78-1
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease Cancer

FAZ-3780 is an inhibitor that binds to the NTF2L domain of G3BP1/2. FAZ-3780 binds to the NTF2L nsP3 of G3BP1 with high affinity, with a Kd of 0.15 μM and a Pep-FRET IC50 of 0.7 μM. FAZ-3780 targets the protein-protein interaction domain of G3BP1/2, and specifically inhibits the co-condensation of G3BP1, caprin 1 and RNA in vitro. FAZ-3780 inhibits stress granule formation and disassembles pre-formed stress granules. FAZ-3780 can be used in studies related to cancer and neurodegenerative diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-131649
CAS No.: 15533-09-2
Purity:  99.32%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis .
loading...
    loading...
Cat. No.: HY-170872
CAS No.: 3126212-40-3
Research Areas:  

Cancer

PT-129 is a G3BP1/G3BP2 PROTAC degrader. PT-129 inhibits the formation of stress granules, disassembles pre-existing stress granules, disrupts stress granule-mediated ATF4 trafficking via migratory exocytosis, and suppresses cancer cell proliferation. PT-129 is applicable to the research of lung cancer and melanoma .
loading...
    loading...
Cat. No.: HY-124072
CAS No.: 1186371-31-2
HL001 is an orally active small molecule inhibitor of Cyclophilin A (CypA) and a receptor antagonist of Lysophosphatidic acid 1 (LPA1). HL001 induces cell cycle arrest and apoptosis of tumor cells by p53. HL001 stabilizes p53 by down-regulating G3BP1, inducing reactive oxygen species and DNA damage. HL001 disrupts the interaction between MDM2 and p53-72R in a CypA dependent manner. HL001 has antitumor activity. HL001 can also be used to study pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-162288R
CAS No.: 3036029-72-5
Research Areas:  

Cancer

FAZ-3532 (Standard) is the analytical standard of FAZ-3532 (HY-162288). This product is intended for research and analytical applications. FAZ-3532 is a G3BP inhibitor (Kd = 0.54 μM) which binds to the NTF2L nsP3 binding pocket in G3BP1. FAZ-3532 disrupts the co-condensation of RNA, G3BP1, and caprin 1. FAZ-3532 inhibits G3BP-driven stress granule formation. FAZ-3532 can be studied as a powerful tool to probe the biology of stress granules and a promising interventions designed to modulate stress granule formation .
loading...
    loading...